Blood pressure and renal function before and after percutaneous transluminal renal angioplasty in fibromuscular dysplasia: A cohort study

Journal of Hypertension

Volumn 31, Issue 6, 2013, Pages 1183-1188

  Smit, Jasper V ^a   Wierema, Thomas K A ^b   Kroon, Abraham A ^a   De Leeuw, Peter W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CPRLab   (Netherlands)

Author keywords

cohort studies; fibromuscular dysplasia; hypertension; percutaneous transluminal angioplasty; renal artery stenosis; revascularization

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; RENIN INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FIBROMUSCULAR DYSPLASIA; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY; PRIORITY JOURNAL; RENAL ARTERY;

EID: 84877577883     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32836044b2     Document Type: Article

References (16)

1. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg 2008; 48:865-871.
2. de Fraissinette B, Garcier JM, Dieu V, Mofid R, Ravel A, Boire JY, et al. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol 2003; 26:46-51.
3. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002; 23:146-152.
4. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48:1936-1945.
5. Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995; 70:1041-1052.
6. Martinez-Amenos A, Rama H, Sarrias X, Galceran J, Alsina J, Montanya X. Percutaneous transluminal angioplasty in the treatment of renovascular hypertension. J Hum Hypertens 1991; 5:97-100.
7. Luscher TF, Keller HM, Imhof HG, Greminger P, Kuhlmann U, Largiader F, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986; 44 (Suppl 1):109-114.
8. Grim CE, Yune HY, Donohue JP, Weinberger MH, Dilley R, Klatte EC. Renal vascular hypertension. Surgery vs. dilation. Nephron 1986; 44 (Suppl 1):96-100.
9. Kuhlmann U, Greminger P, Gruntzig A, Schneider E, Pouliadis G, Luscher T, et al. Long-term experience in percutaneous transluminal dilatation of renal artery stenosis. Am J Med 1985; 79:692-698.
10. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309:274-279.
11. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans-Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463-e654.
12. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2011. Oslo, 2010.
13. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 2002; 106:1572-1585.
14. LeveyAS,BoschJP,LewisJB,GreeneT,RogersN,RothD.Amoreaccurate methodtoestimateglomerular filtrationrate fromserumcreatinine: anew prediction equation. Ann Intern Med 1999; 130:461-470.
15. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350:1862-1871.
16. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56:525-532.